Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Associated Press - August 12, 2009
Gilead spokesman Nathan Kaiser said Wednesday the decision to close the offices was prompted by the company's $1.4 billion acquisition of Palo Alto, Calif.-based CV Therapeutics earlier this year.
About half the Colorado employees were offered the opportunity to relocate to California. The Foster City, Calif.-based Gilead has a total of 139 employees in Boulder and Westminster.
Gilead's announcement follows one by OSI Pharmaceutical Inc. that it was closing some U.S. offices, including its Boulder facility, and moving those positions to New York.
------
Information from: Daily Camera, http://www.dailycamera.com/
090812
AP090814
Copyright © 2009 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .